Details for Patent: 11,752,092
✉ Email this page to a colleague
Which drugs does patent 11,752,092 protect, and when does it expire?
Patent 11,752,092 protects RISVAN and is included in one NDA.
This patent has one hundred and ninety-six patent family members in thirty-six countries.
Summary for Patent: 11,752,092
| Title: | Methods for the preparation of injectable depot compositions |
| Abstract: | Injectable depot compositions comprising a biocompatible polymer which is a polymer or copolymer based on lactic acid and/or lactic acid plus glycolic acid having a monomer ratio of lactic to glycolic acid in the range from 48:52 to 100:0, a water-miscible solvent having a dipole moment of about 3.7-4.5 D and a dielectric constant of between 30 and 50, and a drug, were found suitable for forming in-situ biodegradable implants which can evoke therapeutic drug plasma levels from the first day and for at least 14 days. |
| Inventor(s): | Ibon GUTIERRO ADURIZ, Maria Teresa Gomez Ochoa |
| Assignee: | Laboratorios Farmaceuticos Rovi SA |
| Application Number: | US17/104,337 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Device; |
Drugs Protected by US Patent 11,752,092
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Labs Farms Rovi Sa | RISVAN | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 214835-001 | Mar 29, 2024 | DISCN | Yes | No | 11,752,092 | ⤷ Start Trial | ADMINISTRATION OF RISPERIDONE IN EXTENDED RELEASE INJECTABLE SUSPENSION FOR TREATMENT OF SCHIZOPHRENIA IN ADULTS | ⤷ Start Trial | ||||
| Labs Farms Rovi Sa | RISVAN | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 214835-002 | Mar 29, 2024 | DISCN | Yes | No | 11,752,092 | ⤷ Start Trial | ADMINISTRATION OF RISPERIDONE IN EXTENDED RELEASE INJECTABLE SUSPENSION FOR TREATMENT OF SCHIZOPHRENIA IN ADULTS | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,752,092
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 3524 | ⤷ Start Trial | |||
| Australia | 2011260318 | ⤷ Start Trial | |||
| Australia | 2013269546 | ⤷ Start Trial | |||
| Australia | 2013269547 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
